Endodiabetes Ltd
07965488
Healthy
No risk factors detected.
Details
Compliance
Last accounts
28/02/2025
micro entity
Next accounts due
30/11/2026
Confirmation statement
Last: 26/10/2025
Due 09/11/2026
Industry
Officers
Persons with Significant Control
Dr Nemanja Stojanovic
British · United Kingdom · Age 60
The Company's Registered Office, London, N2 8EY
Notified 01/07/2016
CompanyRankvs 3047+ SIC 59112 peers70
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 28/02/2025
Net Worth
£80k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£14k
Working capital
Current Assets
£33k
Current Liabilities
£19k
Fixed Assets
£66k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.72 | +£12k |
| 2024 | 1.34 | +£27k |
| 2023 | 0.50 | +£8k |
| 2022 | 3.89 | +£13k |
| 2021 | 2.65 | +£9k |
| 2020 | 3.05 | +£251 |
| 2019 | 2.32 | — |
Derived from filed accounts. Not audited figures.